| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―May―22 |
Role of N-linked glycosylation in porcine reproductive and respiratory syndrome virus (PRRSV) infection |
Raymond R.R. Rowland, Alberto Brandariz-Nuñez |
| 2 |
[GO] |
2024―May―08 |
Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic |
Yalcin Kara, Mahmut Can Kizil, Merve İşeri Nepesov, Ebru Kaçmaz, Eylem Kiral, Gurkan Bozan, Gül Durmaz, Tercan Us, Ömer Kiliç, Ener Çağrı Dinleyici |
| 3 |
[GO] |
2024―Jan―25 |
Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein |
Christopher L. D. McMillan, Danushka K. Wijesundara, Jovin J. Y. Choo, Alberto A. Amarilla, Naphak Modhiran, Germain J. P. Fernando, Alexander A. Khromykh, Daniel Watterson, Paul R. Young, David A. Muller |
| 4 |
[GO] |
2023―Dec―07 |
Lack of detection of SARS-CoV-2 in British wildlife 2020-21 and first description of a stoat (Mustela erminea) Minacovirus |
Ternenge Apaa, Amy J. Withers, Laura Mackenzie, Ceri Staley, Nicola Dessi, Adam Blanchard, Malcolm Bennett, Samantha Bremner-Harrison, Elizabeth A. Chadwick, Frank Hailer, Stephen W. R. Harrison, Xavier Lambin, Matthew Loose, Fiona Mathews, Rachael Tarlinton |
| 5 |
[GO] |
2023―Nov―24 |
Evolution of the coronavirus spike protein in the full-length genome and defective viral genome under diverse selection pressures |
Ching-Hung Lin, Hon-Man-Herman Tam, Cheng-Yao Yang, Feng-Cheng Hsieh, Jiun-Long Wang, Chun-Chun Yang, Hsuan-Wei Hsu, Hao-Ping Liu, Hung-Yi Wu |
| 6 |
[GO] |
2023―Nov―10 |
SARS-CoV-2 and the DNA damage response |
Roger J. Grand |
| 7 |
[GO] |
2023―Oct―10 |
Desmoglein-2 and COVID-19 complications: insights into its role as a biomarker, pathogenesis and clinical implications |
Chidiebere F. Uchechukwu, Uchechukwu Love Anyaduba, Chukwuemeka Chinedum Udekwu, Oluwatosin Qawiyy Orababa, Ayomikun Emmanuel Kade |
| 8 |
[GO] |
2023―Oct―06 |
MERS-CoV and SARS-CoV-2 membrane proteins are modified with polylactosamine chains |
Dylan Juckel, Lowiese Desmarets, Adeline Danneels, Yves Rouillé, Jean Dubuisson, Sandrine Belouzard |
| 9 |
[GO] |
2023―Aug―31 |
A novel chimeric vaccine candidate for porcine reproductive and respiratory syndrome virus (PRRSV) I and II elicits neutralizing antibodies against both types |
Sang-Ho Cha, Bang-Hun Hyun, Hyang-Sim Lee, Seok-Jin Kang, Su-Hwa You, Jiwoon Jeong, Chang-Joo Park, Myung-Shin Lee, Changhoon Park |
| 10 |
[GO] |
2023―Aug―31 |
Continued adaptation of A/H2N2 viruses during pandemic circulation in humans |
Jasmin S. Kutter, Martin Linster, Dennis de Meulder, Theo M. Bestebroer, Pascal Lexmond, Miruna E. Rosu, Mathilde Richard, Robert P. de Vries, Ron A. M. Fouchier, Sander Herfst |
| 11 |
[GO] |
2023―Jul―26 |
Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2 |
Mark Thursz, Fouzia Sadiq, Julia A. Tree, Peter Karayiannis, David W. C. Beasley, Wanwissa Dejnirattisai, Juthathip Mongkolsapaya, Gavin Screaton, Matthew Wand, Michael J. Elmore, Miles W. Carroll, Ian Matthews, Howard Thomas |
| 12 |
[GO] |
2023―Jul―11 |
Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2 |
Mark Thursz, Fouzia Sadiq, Julia A. Tree, Peter Karayiannis, David W. C. Beasley, Wanwissa Dejnirattisai, Juthathip Mongkolsapaya, Gavin Screaton, Matthew Wand, Michael J. Elmore, Miles W. Carroll, Ian Matthews, Howard Thomas |
| 13 |
[GO] |
2023―Jun―21 |
ARF6 is a host factor for SARS-CoV-2 infection in vitro |
C. Mirabelli, J. Bragazzi Cunha, J. W. Wotring, E. J. Sherman, J. El Saghir, J. Harder, M. Kretzler, J. Z. Sexton, B. T. Emmer, C. E. Wobus |
| 14 |
[GO] |
2023―May―11 |
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1 |
David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, Arturo Casadevall, Daniele Focosi |
| 15 |
[GO] |
2023―Feb―17 |
The health of influenza surveillance and pandemic preparedness in the wake of the COVID-19 pandemic |
Rodney Stuart Daniels, John William McCauley |
| 16 |
[GO] |
2023―Feb―14 |
A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model |
Kevin Purves, Ruth Haverty, Tiina O'Neill, David Folan, Sophie O'Reilly, Alan W. Baird, Dimitri Scholz, Patrick W. Mallon, Virginie Gautier, Michael Folan, Nicola F. Fletcher |
| 17 |
[GO] |
2022―Nov―22 |
Infectious droplet exposure is an inefficient route for SARS-CoV-2 infection in the ferret model |
Joe James, Alexander M. P. Byrne, Hooman Goharriz, Megan Golding, Joan M. A. Cuesta, Benjamin C. Mollett, Rebecca Shipley, Lorraine M. McElhinney, Anthony R. Fooks, Sharon M. Brookes |
| 18 |
[GO] |
2022―Oct―25 |
Retraction notice: The middle half genome of interferon-inducing porcine reproductive and respiratory syndrome virus strain A2MC2 is essential for interferon induction |
|
| 19 |
[GO] |
2022―May―04 |
Mutations within scavenger receptor cysteine-rich (SRCR) protein domain 5 of porcine CD163 involved in infection with porcine reproductive and respiratory syndrome virus (PRRS) |
Ana M. M. Stoian, Raymond R. R. Rowland, Alberto Brandariz-Nuñez |
| 20 |
[GO] |
2022―Apr―04 |
SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges |
Nazia Thakur, Giulia Gallo, Joseph Newman, Thomas P. Peacock, Luca Biasetti, Catherine N. Hall, Edward Wright, Wendy Barclay, Dalan Bailey |
| 21 |
[GO] |
2022―Jan―11 |
Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2 |
Katarzyna Piadel, Amin Haybatollahi, Angus George Dalgleish, Peter Lawrence Smith |
| 22 |
[GO] |
2021―Nov―24 |
Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples |
Aleksander Szymczak, Natalia Jędruchniewicz, Alessandro Torelli, Agata Kaczmarzyk-Radka, Rosa Coluccio, Marlena Kłak, Andrzej Konieczny, Stanisław Ferenc, Wojciech Witkiewicz, Emanuele Montomoli, Paulina Miernikiewicz, Remigiusz Bąchor, Krystyna Dąbrowska |
| 23 |
[GO] |
2021―Nov―17 |
Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale |
Kelvinson Viana, Luis Zarpelon, Andre Leandro, Maria Terencio, Renata Lopes, Caroline Martins, Isaak Silva, Alessandra Sibim, Fábio Marques, Rafael da Silva, Açucena Rivas, Adrieli Souza, Angelo dos-Santos, Sara Torres, Maria Garcia, Rodolfo Giunchetti, Wagner Chiba-de-Castro |
| 24 |
[GO] |
2021―Oct―27 |
MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation |
Yuting Jiang, Yuehong Chen, Hong Sun, Xiaolu Zhang, Lei He, Jiangfan Li, Guangyu Zhao, Shihui Sun |
| 25 |
[GO] |
2021―Oct―08 |
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2 |
Laura Olbrich, Noemi Castelletti, Yannik Schälte, Mercè Garí, Peter Pütz, Abhishek Bakuli, Michael Pritsch, Inge Kroidl, Elmar Saathoff, Jessica Michelle Guggenbuehl Noller, Volker Fingerle, Ronan Le Gleut, Leonard Gilberg, Isabel Brand, Philine Falk, Alisa Markgraf, Flora Deák, Friedrich Riess, Max Diefenbach, Tabea Eser, Franz Weinauer, Silke Martin, Ernst-Markus Quenzel, Marc Becker, Jürgen Durner, Philipp Girl, Katharina Müller, Katja Radon, Christiane Fuchs, Roman Wölfel, Jan Hasenauer, Michael Hoelscher, Andreas Wieser |
| 26 |
[GO] |
2021―Sep―15 |
Prevalence and molecular characteristics of feline coronavirus in southwest China from 2017 to 2020 |
Qun Zhou, Yan Li, Jian Huang, Nengsheng Fu, Xin Song, Xue Sha, Bin Zhang |
| 27 |
[GO] |
2021―Aug―23 |
Analysis of the avian coronavirus spike protein reveals heterogeneity in the glycans present |
Phoebe Stevenson-Leggett, Stuart Armstrong, Sarah Keep, Paul Britton, Erica Bickerton |
| 28 |
[GO] |
2021―Jul―28 |
Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir |
Marie O. Pohl, Idoia Busnadiego, Francesco Marrafino, Lars Wiedmer, Annika Hunziker, Sonja Fernbach, Irina Glas, Elena V. Moroz-Omori, Benjamin G. Hale, Amedeo Caflisch, Silke Stertz |
| 29 |
[GO] |
2021―Jun―16 |
Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom |
Joseph G. Chappell, Theocharis Tsoleridis, Gemma Clark, Louise Berry, Nadine Holmes, Christopher Moore, Matthew Carlile, Fei Sang, Bisrat J. Debebe, Victoria Wright, William L. Irving, Brian J. Thomson, Timothy C. J. Boswell, Iona Willingham, Amelia Joseph, Wendy Smith, Manjinder Khakh, Vicki M. Fleming, Michelle M. Lister, Hannah C. Howson-Wells, Edward C. Holmes, Matthew W. Loose, Jonathan K. Ball, C. Patrick McClure |
| 30 |
[GO] |
2021―May―06 |
Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells |
Thrimendra Kaushika Dissanayake, Bingpeng Yan, Anthony Chin-Ki Ng, Hanjun Zhao, Gabriella Chan, Cyril Chik-Yan Yip, Kong-Hung Sze, Kelvin Kai-Wang To |
| 31 |
[GO] |
2021―May―06 |
SARS-CoV-2 replicon for high-throughput antiviral screening |
Qiu-Yan Zhang, Cheng-Lin Deng, Jing Liu, Jia-Qi Li, Hong-Qing Zhang, Na Li, Ya-Nan Zhang, Xiao-Dan Li, Bo Zhang, Yi Xu, Han-Qing Ye |
| 32 |
[GO] |
2021―Apr―29 |
Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes |
Katherine Davies, Hubert Buczkowski, Stephen R. Welch, Nicole Green, Damian Mawer, Neil Woodford, Allen D. G. Roberts, Peter J. Nixon, David W. Seymour, Marian J. Killip |
| 33 |
[GO] |
2021―Apr―23 |
Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2 |
Sophie J. Smither, Lin S. Eastaugh, James S. Findlay, Thomas R. Laws, Stephen N. Marriott, Stuart Notman, Lyn M. O’Brien, Amanda L. Phelps, Mark Richards, David Ulaeto, Pat Watts, Mark S. Lever, Norman Govan |
| 34 |
[GO] |
2021―Apr―15 |
SARS-CoV-2 one year on: evidence for ongoing viral adaptation |
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, Wendy S. Barclay |
| 35 |
[GO] |
2021―Apr―08 |
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection |
Lisa Henss, Arne Auste, Christoph Schürmann, Christin Schmidt, Christine von Rhein, Michael D. Mühlebach, Barbara S. Schnierle |
| 36 |
[GO] |
2021―Feb―22 |
Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2 |
Elodie Monchatre-Leroy, Sandrine Lesellier, Marine Wasniewski, Evelyne Picard-Meyer, Céline Richomme, Franck Boué, Sandra Lacôte, Séverine Murri, Coralie Pulido, Johann Vulin, Francisco J. Salguero, Meriadeg Ar Gouilh, Alexandre Servat, Philippe Marianneau |
| 37 |
[GO] |
2021―Feb―15 |
A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India |
Asmita Gupta, Radhakrishnan Sabarinathan, Pratyusha Bala, Vinay Donipadi, Divya Vashisht, Madhumohan Rao Katika, Manohar Kandakatla, Debashis Mitra, Ashwin Dalal, Murali Dharan Bashyam |
| 38 |
[GO] |
2021―Jan―28 |
Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19 |
Molly K. Roe, Nathan A. Junod, Audrey R. Young, Dia C. Beachboard, Christopher C. Stobart |
| 39 |
[GO] |
2021―Jan―11 |
A genetic element in the SARS-CoV-2 genome is shared with multiple insect species |
Torstein Tengs, Charles F. Delwiche, Christine Monceyron Jonassen |
| 40 |
[GO] |
2021―Jan―08 |
Assessment of inactivation procedures for SARS-CoV-2 |
Heidi Auerswald, Sokhoun Yann, Sokha Dul, Saraden In, Philippe Dussart, Nicholas J. Martin, Erik A. Karlsson, Jose A. Garcia-Rivera |
| 41 |
[GO] |
2020―Dec―17 |
Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit? |
Peter Simmonds, Sarah Williams, Heli Harvala |
| 42 |
[GO] |
2020―Nov―05 |
Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression |
Zhou Shen, Guangxu Zhang, Yilin Yang, Mengxia Li, Siqi Yang, Guiqing Peng |
| 43 |
[GO] |
2020―Sep―30 |
Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020 |
Mark Harris |
| 44 |
[GO] |
2020―Sep―09 |
Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus |
Arinjay Banerjee, Andrew C. Doxey, Benjamin J.-M. Tremblay, Michael J. Mansfield, Sonu Subudhi, Jeremy A. Hirota, Matthew S. Miller, Andrew G. McArthur, Samira Mubareka, Karen Mossman |
| 45 |
[GO] |
2020―Sep―09 |
Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses |
David A. Wilkinson, Léa Joffrin, Camille Lebarbenchon, Patrick Mavingui |
| 46 |
[GO] |
2020―Sep―07 |
Construction and efficacy evaluation of novel swine leukocyte antigen (SLA) class I and class II allele-specific poly-T cell epitope vaccines against porcine reproductive and respiratory syndrome virus |
Debin Tian, Sakthivel Subramaniam, C. Lynn Heffron, Hassan M. Mahsoub, Harini Sooryanarain, Bo Wang, Qian M. Cao, Anna Hassebroek, Tanya LeRoith, Dennis L. Foss, Jay G. Calvert, Xiang-Jin Meng |
| 47 |
[GO] |
2020―Aug―21 |
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients |
William B. Klimstra, Natasha L. Tilston-Lunel, Sham Nambulli, James Boslett, Cynthia M. McMillen, Theron Gilliland, Matthew D. Dunn, Chengun Sun, Sarah E. Wheeler, Alan Wells, Amy L. Hartman, Anita K. McElroy, Douglas S. Reed, Linda J. Rennick, W. Paul Duprex |
| 48 |
[GO] |
2020―Jul―28 |
Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virus |
Sarah Keep, Michael S. Oade, Filip Lidzbarski-Silvestre, Kirsten Bentley, Phoebe Stevenson-Leggett, Graham L. Freimanis, Chandana Tennakoon, Nicholas Sanderson, John A. Hammond, Richard C. Jones, Paul Britton, Erica Bickerton |
| 49 |
[GO] |
2020―Jul―15 |
A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a |
Andrew E. Firth |
| 50 |
[GO] |
2020―Jun―24 |
Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems |
Severino Jefferson Ribeiro da Silva, Renata Pessôa Germano Mendes, Caroline Targino Alves da Silva, Alessio Lorusso, Alain Kohl, Lindomar Pena |
| 51 |
[GO] |
2020―Jun―15 |
Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection |
Jingfang Wang, Xintian Xu, Xinbo Zhou, Ping Chen, Huiying Liang, Xuan Li, Wu Zhong, Pei Hao |
| 52 |
[GO] |
2020―May―20 |
The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection |
Paul Kellam, Wendy Barclay |
|
